BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Argikar UA, Dumouchel JL, Dunne CE, Bushee AJ. Ocular non-P450 oxidative, reductive, hydrolytic, and conjugative drug metabolizing enzymes. Drug Metab Rev 2017;49:372-94. [PMID: 28438049 DOI: 10.1080/03602532.2017.1322609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Dumouchel JL, Argikar UA, Adams CM, Prasanna G, Ehara T, Kim S, Breen C, Mogi M. Understanding metabolism related differences in ocular efficacy of MGV354. Xenobiotica 2021;51:5-14. [PMID: 32662714 DOI: 10.1080/00498254.2020.1794658] [Reference Citation Analysis]
2 Balhara A, Basit A, Argikar UA, Dumouchel JL, Singh S, Prasad B. Comparative Proteomics Analysis of the Postmitochondrial Supernatant Fraction of Human Lens-Free Whole Eye and Liver. Drug Metab Dispos 2021;49:592-600. [PMID: 33952609 DOI: 10.1124/dmd.120.000297] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Dumouchel JL, Kramlinger VM. Case Study 10: A Case to Investigate Acetyl Transferase Kinetics. Methods Mol Biol 2021;2342:781-808. [PMID: 34272717 DOI: 10.1007/978-1-0716-1554-6_29] [Reference Citation Analysis]
4 Soni PK, Saini TR. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by Design of Experiment (DoE) approach. Drug Dev Ind Pharm 2022;:1-50. [PMID: 35484943 DOI: 10.1080/03639045.2022.2070198] [Reference Citation Analysis]
5 Dumouchel JL, Chemuturi N, Milton MN, Camenisch G, Chastain J, Walles M, Sasseville V, Gunduz M, Iyer GR, Argikar UA. Models and Approaches Describing the Metabolism, Transport, and Toxicity of Drugs Administered by the Ocular Route. Drug Metab Dispos 2018;46:1670-83. [DOI: 10.1124/dmd.118.082974] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang R, Gao Y, Liu A, Zhai G. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances. J Drug Target 2021;29:687-702. [PMID: 33474998 DOI: 10.1080/1061186X.2021.1878366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gupta B, Mishra V, Gharat S, Momin M, Omri A. Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems. Pharmaceuticals (Basel) 2021;14:1201. [PMID: 34832983 DOI: 10.3390/ph14111201] [Reference Citation Analysis]
8 Hammid A, Fallon JK, Lassila T, Salluce G, Smith PC, Tolonen A, Sauer A, Urtti A, Honkakoski P. Carboxylesterase Activities and Protein Expression in Rabbit and Pig Ocular Tissues. Mol Pharm 2021;18:1305-16. [PMID: 33595329 DOI: 10.1021/acs.molpharmaceut.0c01154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Burchill MA, Goldberg AR, Tamburini BAJ. Emerging Roles for Lymphatics in Chronic Liver Disease. Front Physiol 2019;10:1579. [PMID: 31992991 DOI: 10.3389/fphys.2019.01579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Del Amo EM, Hammid A, Tausch M, Toropainen E, Sadeghi A, Valtari A, Puranen J, Reinisalo M, Ruponen M, Urtti A, Sauer A, Honkakoski P. Ocular metabolism and distribution of drugs in the rabbit eye: Quantitative assessment after intracameral and intravitreal administrations. Int J Pharm 2021;613:121361. [PMID: 34896561 DOI: 10.1016/j.ijpharm.2021.121361] [Reference Citation Analysis]